{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:42:42Z","timestamp":1779090162384,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.bmc.2012.05.032","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T13:54:59Z","timestamp":1337781299000},"page":"4872-4880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II"],"prefix":"10.1016","volume":"20","author":[{"given":"Jolanta","family":"Obniska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Rzepka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2012.05.032_b0005","series-title":"Goodman & Gilman\u2019s The Phamacological Basis of Therapeutics","first-page":"583","article-title":"Pharmacotherapy of the Epilepsies","author":"McNamara","year":"2011"},{"key":"10.1016\/j.bmc.2012.05.032_b0010","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1528-1167.2008.01579.x","volume":"49","author":"Picot","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.bmc.2012.05.032_b0015","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/ern.10.71","volume":"10","author":"Cramer","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.bmc.2012.05.032_b0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2006.02.004","volume":"69","author":"Rogawski","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bmc.2012.05.032_b0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eplepsyres.2011.08.016","volume":"98","author":"Khan","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bmc.2012.05.032_b0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1021\/jm00154a022","volume":"29","author":"Wong","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0166-1280(00)00364-X","volume":"504","author":"Tasso","year":"2000","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bmc.2012.05.032_b0040","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1016\/j.ejmech.2011.07.043","volume":"46","author":"Kami\u0144ski","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0045","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1016\/j.bmcl.2011.07.118","volume":"21","author":"Kami\u0144ski","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmc.2012.05.032_b0050","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1016\/j.bmc.2008.03.037","volume":"16","author":"Kami\u0144ski","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejmech.2007.02.024","volume":"43","author":"Kami\u0144ski","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jfluchem.2006.01.009","volume":"127","author":"Obniska","year":"2006","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0065","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1016\/j.bmc.2010.06.064","volume":"18","author":"Obniska","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0070","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ejmech.2008.05.020","volume":"44","author":"Obniska","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ardp.200900250","volume":"343","author":"Obniska","year":"2010","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.bmc.2012.05.032_b0080","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0014-827X(03)00187-3","volume":"58","author":"Obniska","year":"2003","journal-title":"Il Farmaco"},{"key":"10.1016\/j.bmc.2012.05.032_b0085","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1021\/ja01154a126","volume":"73","author":"Miller","year":"1951","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bmc.2012.05.032_b0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.bmc.2012.05.032_b0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eplepsyres.2005.09.012","volume":"68","author":"Rogawski","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bmc.2012.05.032_b0100","series-title":"Molecular and Cellular Targets for Antiepileptic Drugs","first-page":"191","article-title":"The NIH Anticonvulsant Drug Development (Add) Program: Preclinical Anticonvulsant Screening Project","author":"Stables","year":"1997"},{"key":"10.1016\/j.bmc.2012.05.032_b0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bmc.2012.05.032_b0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1528-1157.1978.tb04507.x","volume":"19","author":"Krall","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.bmc.2012.05.032_b0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1528-1157.1989.tb05815.x","volume":"30","author":"Kupferberg","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.bmc.2012.05.032_b0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","volume":"46","author":"Dunham","year":"1957","journal-title":"J. Am. Pharm. Assoc. Sci."},{"key":"10.1016\/j.bmc.2012.05.032_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-3565(25)05160-2","volume":"107","author":"Brown","year":"1953","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bmc.2012.05.032_b0130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.0013-9580.2004.04504.x","volume":"45","author":"Kaminski","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.bmc.2012.05.032_b0135","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.bmc.2005.12.041","volume":"14","author":"Thirumurugan","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0140","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1021\/jm050283b","volume":"48","author":"Yogeeswari","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2012.05.032_b0145","series-title":"Antiepileptic Drugs","first-page":"43","author":"White","year":"2002"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089612004063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089612004063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:04:37Z","timestamp":1760832277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089612004063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0968089612004063"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2012.05.032","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2012.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}